Kissei Pharmaceutical Co Ltd
TSE:4547

Watchlist Manager
Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd
TSE:4547
Watchlist
Price: 3 655 JPY -0.95% Market Closed
Market Cap: 161.6B JPY
Have any thoughts about
Kissei Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Kissei Pharmaceutical Co Ltd stock under the Base Case scenario is 2 502.7 JPY. Compared to the current market price of 3 655 JPY, Kissei Pharmaceutical Co Ltd is Overvalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 502.7 JPY
Overvaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Kissei Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Kissei Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Kissei Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Kissei Pharmaceutical Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Kissei Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Kissei Pharmaceutical Co Ltd.

What unique competitive advantages
does Kissei Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Kissei Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kissei Pharmaceutical Co Ltd.

Provide P/S
for Kissei Pharmaceutical Co Ltd.

Provide P/E
for Kissei Pharmaceutical Co Ltd.

Provide P/OCF
for Kissei Pharmaceutical Co Ltd.

Provide P/FCFE
for Kissei Pharmaceutical Co Ltd.

Provide P/B
for Kissei Pharmaceutical Co Ltd.

Provide EV/S
for Kissei Pharmaceutical Co Ltd.

Provide EV/GP
for Kissei Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Kissei Pharmaceutical Co Ltd.

Provide EV/EBIT
for Kissei Pharmaceutical Co Ltd.

Provide EV/OCF
for Kissei Pharmaceutical Co Ltd.

Provide EV/FCFF
for Kissei Pharmaceutical Co Ltd.

Provide EV/IC
for Kissei Pharmaceutical Co Ltd.

Show me price targets
for Kissei Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Kissei Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Kissei Pharmaceutical Co Ltd?

What are the Net Income projections
for Kissei Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Kissei Pharmaceutical Co Ltd?

What are the EPS projections
for Kissei Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Kissei Pharmaceutical Co Ltd?

What are the EBIT projections
for Kissei Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Kissei Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Kissei Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kissei Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kissei Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kissei Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Kissei Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Kissei Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Kissei Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Kissei Pharmaceutical Co Ltd.

Provide ROE
for Kissei Pharmaceutical Co Ltd.

Provide ROA
for Kissei Pharmaceutical Co Ltd.

Provide ROIC
for Kissei Pharmaceutical Co Ltd.

Provide ROCE
for Kissei Pharmaceutical Co Ltd.

Provide Gross Margin
for Kissei Pharmaceutical Co Ltd.

Provide Operating Margin
for Kissei Pharmaceutical Co Ltd.

Provide Net Margin
for Kissei Pharmaceutical Co Ltd.

Provide FCF Margin
for Kissei Pharmaceutical Co Ltd.

Show all solvency ratios
for Kissei Pharmaceutical Co Ltd.

Provide D/E Ratio
for Kissei Pharmaceutical Co Ltd.

Provide D/A Ratio
for Kissei Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Kissei Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Kissei Pharmaceutical Co Ltd.

Provide Quick Ratio
for Kissei Pharmaceutical Co Ltd.

Provide Current Ratio
for Kissei Pharmaceutical Co Ltd.

Provide Cash Ratio
for Kissei Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Kissei Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Kissei Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Kissei Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kissei Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kissei Pharmaceutical Co Ltd

Current Assets 107B
Cash & Short-Term Investments 50B
Receivables 27.4B
Other Current Assets 29.6B
Non-Current Assets 153.3B
Long-Term Investments 100.7B
PP&E 26.1B
Intangibles 1.9B
Other Non-Current Assets 24.7B
Current Liabilities 19.4B
Accounts Payable 5.2B
Accrued Liabilities 1.8B
Short-Term Debt 1.3B
Other Current Liabilities 11.2B
Non-Current Liabilities 21.2B
Other Non-Current Liabilities 21.2B
Efficiency

Earnings Waterfall
Kissei Pharmaceutical Co Ltd

Revenue
81.1B JPY
Cost of Revenue
-40.6B JPY
Gross Profit
40.4B JPY
Operating Expenses
-36.7B JPY
Operating Income
3.8B JPY
Other Expenses
6.9B JPY
Net Income
10.7B JPY

Free Cash Flow Analysis
Kissei Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kissei Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Net Income
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
47/100
Profitability
Score

Kissei Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kissei Pharmaceutical Co Ltd's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
94/100
Solvency
Score

Kissei Pharmaceutical Co Ltd's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kissei Pharmaceutical Co Ltd

Wall Street analysts forecast Kissei Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kissei Pharmaceutical Co Ltd is 3 898.95 JPY with a low forecast of 3 474.4 JPY and a high forecast of 4 620 JPY.

Lowest
Price Target
3 474.4 JPY
5% Downside
Average
Price Target
3 898.95 JPY
7% Upside
Highest
Price Target
4 620 JPY
26% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Kissei Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Kissei Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Kissei Pharmaceutical Co Ltd Logo
Kissei Pharmaceutical Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

161.6B JPY

Dividend Yield

2.35%

Description

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken and currently employs 1,863 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

Contact

NAGANO-KEN
Matsumoto-shi
19-48, Yoshino
+81263259081.0
www.kissei.co.jp

IPO

1988-12-22

Employees

1 863

Officers

Chairman & CEO
Mr. Mutsuo Kanzawa
President, COO & Director
Mr. Yasuo Takehana
GM of Financial Management Department, MD & Director
Mr. Takahide Kitahara
Senior Advisor & Director
Mr. Yoshio Furihata
Executive VP & Director
Mr. Keiji Fukushima
Executive MD & Director
Mr. Tetsu Takayama
Show More
GM of Pharmaceutical Sales Headquarters & Director
Hiroshi Noake
GM of Research Division & Director
Keiji Miyazawa
Show Less

See Also

Discover More
What is the Intrinsic Value of one Kissei Pharmaceutical Co Ltd stock?

The intrinsic value of one Kissei Pharmaceutical Co Ltd stock under the Base Case scenario is 2 502.7 JPY.

Is Kissei Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 3 655 JPY, Kissei Pharmaceutical Co Ltd is Overvalued by 32%.

Back to Top